TITLE

Is Alendronate Clinically Gastrotoxic? Re: Graham et al. Primary Amino-Bisphosphonates: A New Class of Gastrotoxic Drugs--Comparison of Alendronate and Aspirin

AUTHOR(S)
Lanza, Frank; Yates, A. John; Bauer, Douglas C.
PUB. DATE
February 1998
SOURCE
American Journal of Gastroenterology;Feb1998, Vol. 93 Issue 2, p284
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
Presents a letter to the editor about the comparison of alendronate and aspirin.
ACCESSION #
16017226

 

Related Articles

  • Clopidogrel for the Prevention of Atherothrombotic Events. Rabinstein, Alejandro A. // New England Journal of Medicine;7/27/2006, Vol. 355 Issue 4, p418 

    A letter to the editor is presented in response to the article "Clopidogrel and Aspirin Versus Aspirin Alone for the Prevention of Atherothrombotic Events," by D. L. Bhatt, K. A. A. Fox, W. Hacke et al. in the April 20, 2006 issue.

  • Clopidogrel for the Prevention of Atherothrombotic Events. Rozenman, Yoseph // New England Journal of Medicine;7/27/2006, Vol. 355 Issue 4, p418 

    A letter to the editor is presented in response to the article "Clopidogrel and Aspirin Versus Aspirin Alone for the Prevention of Atherothrombotic Events," by D. L. Bhatt, K. A. A. Fox, W. Hacke et al. in the April 20, 2006 issue.

  • Clopidogrel for the Prevention of Atherothrombotic Events. Kongsaengdao, Subsai; Arayawichanont, Arkhom // New England Journal of Medicine;7/27/2006, Vol. 355 Issue 4, p418 

    A letter to the editor is presented in response to the article "Clopidogrel and Aspirin Versus Aspirin Alone for the Prevention of Atherothrombotic Events," by D. L. Bhatt, K. A. A. Fox, W. Hacke et al. in the April 20, 2006 issue.

  • Clopidogrel for the Prevention of Atherothrombotic Events. Almanaseer, Yassar; Desai, Devang M. // New England Journal of Medicine;7/27/2006, Vol. 355 Issue 4, p418 

    A letter to the editor is presented in response to the article "Clopidogrel and Aspirin Versus Aspirin Alone for the Prevention of Atherothrombotic Events," by D. L. Bhatt, K. A. A. Fox, W. Hacke et al. in the April 20, 2006 issue.

  • Clopidogrel for the Prevention of Atherothrombotic Events. Kamalesh, Masoor // New England Journal of Medicine;7/27/2006, Vol. 355 Issue 4, p418 

    A letter to the editor is presented in response to the article "Clopidogrel and Aspirin Versus Aspirin Alone for the Prevention of Atherothrombotic Events," by D. L. Bhatt, K. A. A. Fox, W. Hacke et al. in the April 20, 2006 issue.

  • Clopidogrel for the Prevention of Atherothrombotic Events. Topol, Eric J. // New England Journal of Medicine;7/27/2006, Vol. 355 Issue 4, p418 

    A letter to the editor is presented in response to the article "Clopidogrel and Aspirin Versus Aspirin Alone for the Prevention of Atherothrombotic Events," by D. L. Bhatt, K. A. A. Fox, W. Hacke et al. in the April 20, 2006 issue.

  • Aspirin for the Primary Prevention of Coronary Events. Mehta, J.L. // New England Journal of Medicine;9/19/2002, Vol. 347 Issue 12, p948 

    A letter to the editor is presented in response to the article "Aspirin for the Primary Prevention of Coronary Events" in the May 9, 2002 issue.

  • Aspirin for the Primary Prevention of Coronary Events. Mascitelli, Luca; Pezzetta, Francesca // New England Journal of Medicine;9/19/2002, Vol. 347 Issue 12, p948 

    A letter to the editor is presented in response to the article "Aspirin for the Primary Prevention of Coronary Events" in the May 9, 2002 issue.

  • Aspirin for the Primary Prevention of Coronary Events. Lauer, Michael S. // New England Journal of Medicine;9/19/2002, Vol. 347 Issue 12, p948 

    A response by Michael S. Lauer to several letters to the editor about his article "Aspirin for the Primary Prevention of Coronary Events" in the May 9, 2002 issue is presented.

  • Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin. Maiden, Laurence P.; Harris, Adam W. // New England Journal of Medicine;11/14/2002, Vol. 347 Issue 20, p1623 

    A letter to the editor is presented in response to a study on lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin by researcher Kam Chuen Lai and colleagues in the June 27, 2002 issue.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics